Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Neuhold
M. Neuhold
in patient
Cancer
Immunology
Lymph
Immunotherapy
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumor necrosis factor inhibitors: results through one year of a phase 3b, randomized, controlled study (COSMOS)
2021
Annals of the Rheumatic Diseases
Laura C. Coates
Laure Gossec
E. Theander
Paul Bergmans
M. Neuhold
Chetan S. Karyekar
May Shawi
Wim Noël
Georg Schett
I McInnes
Show All
Source
Cite
Save
Citations (0)
OP0230 EFFICACY AND SAFETY OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO DEMONSTRATED INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION: WEEK 24 RESULTS OF A PHASE 3B, RANDOMIZED, CONTROLLED STUDY
2021
Annals of the Rheumatic Diseases
Laura C. Coates
Laure Gossec
E. Theander
Paul Bergmans
M. Neuhold
Chetan Karyekar
May Shawi
W. Noel
Georg Schett
I McInnes
Show All
Source
Cite
Save
Citations (0)
Preoperative peritumoral immunotherapy in patients with cancer of the oral cavity (COC). Increase in number and function of natural killer (NK) cells in draining lymph nodes (LN)
1985
International Journal of Immunopharmacology
K. Vinzenz
Matejka M
Porteder H
Georg Watzek
M. Neuhold
M. Micksche
Show All
Source
Cite
Save
Citations (0)
1